David E. Stec

7.6k total citations · 2 hit papers
138 papers, 6.0k citations indexed

About

David E. Stec is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, David E. Stec has authored 138 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Molecular Biology, 40 papers in Pediatrics, Perinatology and Child Health and 31 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in David E. Stec's work include Heme Oxygenase-1 and Carbon Monoxide (72 papers), Neonatal Health and Biochemistry (35 papers) and Alcohol Consumption and Health Effects (26 papers). David E. Stec is often cited by papers focused on Heme Oxygenase-1 and Carbon Monoxide (72 papers), Neonatal Health and Biochemistry (35 papers) and Alcohol Consumption and Health Effects (26 papers). David E. Stec collaborates with scholars based in United States, Italy and Czechia. David E. Stec's co-authors include Terry D. Hinds, Trinity Vera, Heather A. Drummond, John E. Hall, Peter A. Hosick, Darren M. Gordon, Richard J. Roman, Joey P. Granger, Alexandre A. da Silva and Abdul‐rizaq Hamoud and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

David E. Stec

135 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways

2022 209 citations Olufunto O. Badmus, Terry D. Hinds et al. profile →
The physiology of bilirubin: health and disease equilibrium

2023 78 citations Libor Vı́tek, Terry D. Hinds et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David E. Stec United States	45	3.1k	1.5k	1.2k	1.2k	1.1k	138	6.0k
Toyoshi Inoguchi Japan	46	3.0k 1.0×	499 0.3×	1.9k 1.6×	2.3k 1.9×	954 0.9×	147	8.3k
Tzong‐Shyuan Lee Taiwan	48	3.3k 1.1×	367 0.3×	503 0.4×	908 0.8×	764 0.7×	150	7.4k
Richard J. Roman United States	49	2.0k 0.6×	561 0.4×	2.1k 1.7×	1.6k 1.4×	347 0.3×	229	7.6k
Vernon W. Dolinsky Canada	39	1.7k 0.6×	738 0.5×	506 0.4×	1.3k 1.1×	781 0.7×	105	4.6k
Tianxin Yang United States	52	3.4k 1.1×	423 0.3×	2.0k 1.7×	1.4k 1.2×	374 0.3×	170	7.9k
Márcia Barbosa Águila Brazil	41	1.2k 0.4×	1.0k 0.7×	1.2k 0.9×	2.6k 2.1×	1.7k 1.5×	166	5.2k
Roland C. Blantz United States	47	2.1k 0.7×	695 0.5×	1.0k 0.9×	1.8k 1.5×	231 0.2×	177	7.4k
Edilia Tapia Mexico	48	2.2k 0.7×	356 0.2×	1.1k 0.9×	1.2k 1.0×	864 0.8×	142	7.1k
Scott C. Thomson United States	44	2.2k 0.7×	533 0.4×	2.8k 2.3×	1.1k 1.0×	271 0.2×	100	6.7k
Chris Baylis United States	44	1.2k 0.4×	1.0k 0.7×	1.0k 0.8×	2.9k 2.4×	331 0.3×	145	7.1k

Countries citing papers authored by David E. Stec

Since Specialization

Citations

This map shows the geographic impact of David E. Stec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Stec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Stec more than expected).

Fields of papers citing papers by David E. Stec

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Stec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Stec. The network helps show where David E. Stec may publish in the future.

Co-authorship network of co-authors of David E. Stec

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Stec. A scholar is included among the top collaborators of David E. Stec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Stec. David E. Stec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stec, David E., et al.. (2024). Mice lacking ASIC2 and βENaC are protected from high-fat-diet-induced metabolic syndrome. Frontiers in Endocrinology. 15. 1449344–1449344.

Kipp, Zachary A., Olufunto O. Badmus, David E. Stec, Brantley Hall, & Terry D. Hinds. (2024). Bilirubin bioconversion to urobilin in the gut-liver-kidney axis: A biomarker for insulin resistance in the Cardiovascular-Kidney-Metabolic (CKM) Syndrome. Metabolism. 163. 156081–156081. 12 indexed citations

Flack, Kyle D., Libor Vı́tek, Christopher S. Fry, David E. Stec, & Terry D. Hinds. (2023). Cutting edge concepts: Does bilirubin enhance exercise performance?. Frontiers in Sports and Active Living. 4. 1040687–1040687. 14 indexed citations

Martin, Brigitte E., Erin B. Taylor, Wenjie Wu, et al.. (2023). Sex and molecular differences in cardiovascular parameters at peak influenza disease in mice. Physiological Genomics. 55(2). 79–89. 1 indexed citations

Lu, Yan, David E. Stec, Ruisheng Liu, Michael J. Ryan, & Heather A. Drummond. (2022). βENaC and ASIC2 associate in VSMCs to mediate pressure-induced constriction in the renal afferent arteriole. American Journal of Physiology-Renal Physiology. 322(5). F498–F511. 5 indexed citations

Hinds, Terry D., et al.. (2020). Bilirubin Nanoparticles Reduce Diet-Induced Hepatic Steatosis, Improve Fat Utilization, and Increase Plasma β-Hydroxybutyrate. Frontiers in Pharmacology. 11. 594574–594574. 74 indexed citations

Bisht, Kavita, Giacomo Canesin, Mailin Li, et al.. (2019). Deletion of Biliverdin Reductase A in Myeloid Cells Promotes Chemokine Expression and Chemotaxis in Part via a Complement C5a–C5aR1 Pathway. The Journal of Immunology. 202(10). 2982–2990. 15 indexed citations

Adeosun, Samuel O., et al.. (2017). A Novel Fluorescence-Based Assay for the Measurement of Biliverdin Reductase Activity. PubMed. 5(13). 35–45. 28 indexed citations

Lü, Yan, Wei Jin, David E. Stec, et al.. (2015). Macula Densa Nitric Oxide Synthase 1β Protects against Salt-Sensitive Hypertension. Journal of the American Society of Nephrology. 27(8). 2346–2356. 53 indexed citations

10.

Hosick, Peter A., Abdulhadi A. AlAmodi, Michael W. Hankins, & David E. Stec. (2015). Chronic treatment with a carbon monoxide releasing molecule reverses dietary induced obesity in mice. Adipocyte. 5(1). 1–10. 26 indexed citations

11.

Hall, Michael E., Romain Harmancey, & David E. Stec. (2015). Lean heart: Role of leptin in cardiac hypertrophy and metabolism. World Journal of Cardiology. 7(9). 511–511. 74 indexed citations

12.

George, Eric M., Peter A. Hosick, David E. Stec, & Joey P. Granger. (2013). Heme Oxygenase Inhibition Increases Blood Pressure in Pregnant Rats. American Journal of Hypertension. 26(7). 924–930. 28 indexed citations

13.

Vera, Trinity, et al.. (2008). Heme oxygenase attenuates angiotensin II-mediated superoxide production in cultured mouse thick ascending loop of Henle cells. American Journal of Physiology-Renal Physiology. 295(4). F1158–F1165. 25 indexed citations

14.

Granger, Joey P., et al.. (2006). Endothelin, the kidney, and hypertension. Current Hypertension Reports. 8(4). 298–303. 34 indexed citations

15.

Jernigan, Nikki L., et al.. (2006). Renal vascular responses to CORM-A1 in the mouse. Pharmacological Research. 54(1). 24–29. 54 indexed citations

16.

Ding, Yueming, David E. Stec, & Curt D. Sigmund. (2001). Genetic Evidence That Lethality in Angiotensinogen-deficient Mice Is Due to Loss of Systemic but Not Renal Angiotensinogen. Journal of Biological Chemistry. 276(10). 7431–7436. 18 indexed citations

17.

Stec, David E., Robin L. Davisson, Ronald E. Haskell, Beverly L. Davidson, & Curt D. Sigmund. (1999). Efficient Liver-specific Deletion of a Floxed Human Angiotensinogen Transgene by Adenoviral Delivery of Cre Recombinasein Vivo. Journal of Biological Chemistry. 274(30). 21285–21290. 74 indexed citations

18.

Stec, David E. & Curt D. Sigmund. (1998). Modifiable Gene Expression in Mice: Kidney-Specific Deletion of a Target Gene via the Cre-loxP System. Nephron Experimental Nephrology. 6(6). 568–575. 18 indexed citations

19.

Powell, C. Thomas, et al.. (1996). Overexpression of protein kinase C-zeta (PKC-zeta) inhibits invasive and metastatic abilities of Dunning R-3327 MAT-LyLu rat prostate cancer cells.. PubMed. 56(18). 4137–41. 33 indexed citations

20.

Pravenec, Michal, Shanshan Lu, Howard J. Jacob, et al.. (1996). Effects of renin gene transfer on blood pressure and renin gene expression in a congenic strain of Dahl salt-resistant rats.. Journal of Clinical Investigation. 97(2). 522–527. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact